Artículos Científicos

Home , Landrace

Editor: NOEL GONZÁLEZ GOTERA Número 114 Diseño: Lic. Roberto Chávez y Liuder Machado. Semana 131213 – 201213 Fotos: Dra. Belkis Romeu e Instituto Finlay La Habana, Cuba.

ARTÍCULOS CIENTÍFICOS

Publicaciones incluidas en PubMED durante el período comprendido entre 13 y el 20 de diciembre de 2013. Con “vaccin*” en título: 134 artículos recuperados.

Vacunas Meningococo (Neisseria meningitidis)

76. A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program.

O'Ryan M, Stoddard J, Toneatto D, Wassil J, Dull PM.

Drugs. 2013 Dec 12. [Epub ahead of print]

PMID: 24338083 [PubMed - as supplied by publisher]

Related citations

Select item 24337749

Vacunas Neumococo (Streptococcus pneumoniae)

7. High nasopharyngeal carriage of non-vaccine serotypes in Western Australian aboriginal people following 10 years of pneumococcal conjugate vaccination.

Collins DA, Hoskins A, Bowman J, Jones J, Stemberger NA, Richmond PC, Leach AJ, Lehmann D.

PLoS One. 2013 Dec 3;8(12):e82280. doi: 10.1371/journal.pone.0082280.

PMID: 24349245 [PubMed - in process] Select item 24349225

38. Pneumococcal Serotype Diversity among Adults in Various Countries, Influenced by Pediatric Pneumococcal Vaccination Uptake.

Grabenstein JD, Weber DJ.

Clin Infect Dis. 2013 Dec 15. [Epub ahead of print]

PMID: 24344141 [PubMed - as supplied by publisher]

Related citations

Select item 24343886

55. Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stability.

Gonçalves VM, Dias WO, Ivana CB, Liberman C, Sbrogio-Almeida ME, Silva EP, Cardoso CP, Alderson M, Robertson G, Maisonneuve JF, Tate A, Anderson P, Malley R, Fratelli F, Leite LC.

Vaccine. 2013 Dec 13. pii: S0264-410X(13)01693-9. doi: 10.1016/j.vaccine.2013.10.091. [Epub ahead of print]

PMID: 24342254 [PubMed - as supplied by publisher]

Related citations

Select item 24342253

85. Methods for a systematic review of pneumococcal conjugate vaccine dosing schedules.

Loo JD, Conklin L, Deloria Knoll M, Fleming-Dutra KE, Park DE, Kirk J, Johnson TS, Goldblatt D, O'Brien KL, Whitney CG.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S182-7. doi: 10.1097/INF.0000000000000085.

PMID: 24336060 [PubMed - in process]

Related citations

Select item 24336059

86. Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers.

Whitney CG, Goldblatt D, O'Brien KL.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S172-81. doi: 10.1097/INF.0000000000000076.

PMID: 24336059 [PubMed - in process]

Related citations

Select item 243360588

87. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization.

Loo JD, Conklin L, Fleming-Dutra KE, Knoll MD, Park DE, Kirk J, Goldblatt D, O'Brien KL, Whitney CG.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S161-71. doi: 10.1097/INF.0000000000000084.

PMID: 24336058 [PubMed - in process]

Related citations

Select item 24336057

88. Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Nasopharyngeal Carriage.

Fleming-Dutra KE, Conklin L, Loo JD, Knoll MD, Park DE, Kirk J, Goldblatt D, Whitney CG, O'Brien KL.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S152-60. doi: 10.1097/INF.0000000000000083.

PMID: 24336057 [PubMed - in process]

Related citations

Select item 24336056

89. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia.

Loo JD, Conklin L, Fleming-Dutra KE, Deloria Knoll M, Park DE, Kirk J, Goldblatt D, O'Brien KL, Whitney CG.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S140-51. doi: 10.1097/INF.0000000000000082.

PMID: 24336056 [PubMed - in process]

Related citations

Select item 24336055

90. The differential impact of coadministered vaccines, geographic region, vaccine product and other covariates on pneumococcal conjugate vaccine immunogenicity.

Park DE, Johnson TS, Nonyane BA, Chandir S, Conklin L, Fleming-Dutra KE, Loo JD, Goldblatt D, Whitney CG, O'Brien KL, Deloria Knoll M.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S130-9. doi: 10.1097/INF.0000000000000081.

PMID: 24336055

[PubMed - in process]

Related citations

Select item 24336054

91. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity.

Deloria Knoll M, Park DE, Johnson TS, Chandir S, Nonyane BA, Conklin L, Fleming-Dutra KE, Loo JD, Goldblatt D, Whitney CG, O'Brien KL.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S119-29. doi: 10.1097/INF.0000000000000079.

PMID: 24336054 [PubMed - in process]

Related citations

Select item 24336053

92. Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Invasive Pneumococcal Disease Among Young Children.

Conklin L, Loo JD, Kirk J, Fleming-Dutra KE, Deloria Knoll M, Park DE, Goldblatt D, O'Brien KL, Whitney CG.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S109-18. doi: 10.1097/INF.0000000000000078.

PMID: 24336053 [PubMed - in process]

Related citations

Select item 24336052

93. Why do we need a systematic review of pneumococcal conjugate vaccine dosing schedules?

O'Brien KL, Goldblatt D, Whitney CG.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S107-8. doi: 10.1097/INF.0000000000000075. No abstract available.

PMID: 24336052 [PubMed - in process]

Related citations

Select item 24335963

127. Determining the cost-effectiveness of adult pneumococcal vaccination strategies.

Smith KJ.

Expert Rev Pharmacoecon Outcomes Res. 2013 Dec 16. [Epub ahead of print]

PMID: 24329002 [PubMed - as supplied by publisher]

Related citations

Select item 24328988

Vacunas Fiebre tifoidea (Salmonella typhi)

60. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.

Pakkanen SH, Kantele JM, Herzog C, Kantele A.

Vaccine. 2013 Dec 13. pii: S0264-410X(13)01690-3. doi: 10.1016/j.vaccine.2013.12.001. [Epub ahead of print]

PMID: 24342246 [PubMed - as supplied by publisher]

Related citations

Select item 24342164

Vacuna Tuberculosis (Mycobacterium tuberculosis)

10. ESAT-6 (EsxA) and TB10.4 (EsxH) Based Vaccines for Pre- and Post-Exposure Tuberculosis Vaccination.

Hoang T, Aagaard C, Dietrich J, Cassidy JP, Dolganov G, Schoolnik GK, Lundberg CV, Agger EM, Andersen P.

PLoS One. 2013 Dec 12;8(12):e80579. doi: 10.1371/journal.pone.0080579.

PMID: 24349004 [PubMed - in process] Select item 24348931

Adyuvantes

18. Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant Platform.

Pérez O, Romeu B, Cabrera O, González E, Batista-Duharte A, Labrada A, Pérez R, Reyes LM, Ramírez W, Sifontes S, Fernández N, Lastre M.

Front Immunol. 2013 Dec 2;4:407. Review.

PMID: 24348475 [PubMed - as supplied by publisher] Select item 24348242

29. Chitosan: A promising safe and immune-enhancing adjuvant for intranasal vaccines.

Smith A, Perelman M, Hinchcliffe M.

Hum Vaccin Immunother. 2013 Dec 17;10(3). [Epub ahead of print] Review.

PMID: 24346613 [PubMed - as supplied by publisher] Select item 24346604

Vacunas, otras

1. Next generation inactivated polio vaccine manufacturing to support post polio- eradication biosafety goals.

Thomassen YE, van 't Oever AG, van Oijen MG, Wijffels RH, van der Pol LA, Bakker WA.

PLoS One. 2013 Dec 12;8(12):e83374. doi: 10.1371/journal.pone.0083374.

PMID: 24349497 [PubMed - in process]

Select item 24349407 2.

Recall responses to tetanus and diphtheria vaccination are frequently insufficient in elderly persons.

Weinberger B, Schirmer M, Matteucci Gothe R, Siebert U, Fuchs D, Grubeck- Loebenstein B.

PLoS One. 2013 Dec 11;8(12):e82967. doi: 10.1371/journal.pone.0082967.

PMID: 24349407 [PubMed - in process]

Select item 24349390 3.

Near-infrared laser adjuvant for influenza vaccine.

Kashiwagi S, Yuan J, Forbes B, Hibert ML, Lee EL, Whicher L, Goudie C, Yang Y, Chen T, Edelblute B, Collette B, Edington L, Trussler J, Nezivar J, Leblanc P, Bronson R, Tsukada K, Suematsu M, Dover J, Brauns T, Gelfand J, Poznansky MC.

PLoS One. 2013 Dec 11;8(12):e82899. doi: 10.1371/journal.pone.0082899.

PMID: 24349390 [PubMed - in process]

Select item 24349359 4.

Is obesity a risk factor for vaccine non-responsiveness?

Young KM, Gray CM, Bekker LG.

PLoS One. 2013 Dec 11;8(12):e82779. doi: 10.1371/journal.pone.0082779.

PMID: 24349359 [PubMed - in process] 6

Select item 24349329 5.

A vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreading.

Gottschalk S, Yu F, Ji M, Kakarla S, Song XT.

PLoS One. 2013 Dec 12;8(12):e82658. doi: 10.1371/journal.pone.0082658.

PMID: 24349329 [PubMed - in process]

Select item 24349306 6.

Interleukin-Encoding Adenoviral Vectors as Genetic Adjuvant for Vaccination against Retroviral Infection.

Ohs I, Windmann S, Wildner O, Dittmer U, Bayer W.

PLoS One. 2013 Dec 4;8(12):e82528. doi: 10.1371/journal.pone.0082528.

PMID: 24349306 [PubMed - in process]

Select item 24349245 7.

High nasopharyngeal carriage of non-vaccine serotypes in Western Australian aboriginal people following 10 years of pneumococcal conjugate vaccination.

Collins DA, Hoskins A, Bowman J, Jones J, Stemberger NA, Richmond PC, Leach AJ, Lehmann D.

PLoS One. 2013 Dec 3;8(12):e82280. doi: 10.1371/journal.pone.0082280.

PMID: 24349245 [PubMed - in process]

Select item 24349225 8.

Safety, immunogenicity and duration of immunity elicited by an inactivated bovine ephemeral Fever vaccine.

Aziz-Boaron O, Leibovitz K, Gelman B, Kedmi M, Klement E.

PLoS One. 2013 Dec 12;8(12):e82217. doi: 10.1371/journal.pone.0082217.

PMID: 24349225 [PubMed - in process]

Select item 24349218 9.

Attenuation of CCl4-Induced Hepatic Fibrosis in Mice by Vaccinating against TGF-β1.

Fan X, Zhang Q, Li S, Lv Y, Su H, Jiang H, Hao Z.

PLoS One. 2013 Dec 11;8(12):e82190. doi: 10.1371/journal.pone.0082190.

PMID: 24349218 [PubMed - in process]

Select item 24349004 10.

ESAT-6 (EsxA) and TB10.4 (EsxH) Based Vaccines for Pre- and Post-Exposure Tuberculosis Vaccination.

Hoang T, Aagaard C, Dietrich J, Cassidy JP, Dolganov G, Schoolnik GK, Lundberg CV, Agger EM, Andersen P.

PLoS One. 2013 Dec 12;8(12):e80579. doi: 10.1371/journal.pone.0080579.

PMID: 24349004 [PubMed - in process]

Select item 24348931 11.

Correction: High-Throughput Profiling of Anti-Glycan Humoral Responses to SIV Vaccination and Challenge.

Campbell CT, Llewellyn SR, Demberg T, Morgan IL, Robert-Guroff M, Gildersleeve JC.

PLoS One. 2013 Dec 3;8(12). doi: 10.1371/annotation/fd9f4a65-3f27-46cd-8ed0- 6c9b8ba7f83b.

PMID: 24348931 [PubMed - as supplied by publisher]

Select item 24348705 12.

The long-term effects of a kampo medicine, juzentaihoto, on maintenance of antibody titer in elderly people after influenza vaccination.

Saiki I, Koizumi K, Goto H, Inujima A, Namiki T, Raimura M, Kogure T, Tatsumi T, Inoue H, Sakai S, Oka H, Fujimoto M, Hikiami H, Sakurai H, Shibahara N, Shimada Y, Origasa H.

Evid Based Complement Alternat Med. 2013;2013:568074. doi: 10.1155/2013/568074. Epub 2013 Nov 18.

PMID: 24348705 [PubMed]

Select item 24348684 13.

Tumor Protective Activity of CD4+ but Not of CD8+ T Cells in DNA-Vaccinated Mice Challenged with bcr-abl-Transformed Cells.

Petráčková M, Lučanský V, Vonka V.

Clin Dev Immunol. 2013;2013:923107. doi: 10.1155/2013/923107. Epub 2013 Nov 21.

PMID: 24348684 [PubMed - in process]

Select item 24348673 14.

Haemophilus parasuis Subunit Vaccines Based on Native Proteins with Affinity to Porcine Transferrin Prevent the Expression of Proinflammatory Chemokines and Cytokines in Pigs.

Frandoloso R, Martínez-Martínez S, Rodríguez-Ferri EF, Yubero S, Rodríguez-Lázaro D, Hernández M, Gutiérrez-Martín CB.

Clin Dev Immunol. 2013;2013:132432. doi: 10.1155/2013/132432. Epub 2013 Nov 21.

PMID: 24348673 [PubMed - in process]

Select item 24348658 15.

Prevalence of rotavirus genotypes in South Korea in 1989-2009: implications for a nationwide rotavirus vaccine program.

Than VT, Kim W.

Korean J Pediatr. 2013 Nov;56(11):465-473. Epub 2013 Nov 27. Review.

PMID: 24348658 [PubMed - as supplied by publisher]

Select item 24348639 16.

Hepatitis B: knowledge, vaccine situation and seroconversion of dentistry students of a public university.

Sacchetto MS, Barros SS, Araripe Tde A, Silva AM, Faustino SK, da Silva JM.

Hepat Mon. 2013 Oct 5;13(10):e13670. doi: 10.5812/hepatmon.13670.

PMID: 24348639 [PubMed]

Select item 24348481 17.

Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go.

Vasaturo A, Di Blasio S, Peeters DG, de Koning CC, de Vries JM, Figdor CG, Hato SV.

Front Immunol. 2013 Dec 3;4:417. Review.

PMID: 24348481 [PubMed - as supplied by publisher]

Select item 24348475 18.

Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant Platform.

Pérez O, Romeu B, Cabrera O, González E, Batista-Duharte A, Labrada A, Pérez R, Reyes LM, Ramírez W, Sifontes S, Fernández N, Lastre M.

Front Immunol. 2013 Dec 2;4:407. Review.

PMID: 24348475 [PubMed - as supplied by publisher]

Select item 24348242 19.

The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.

Vanblargan LA, Mukherjee S, Dowd KA, Durbin AP, Whitehead SS, Pierson TC.

PLoS Pathog. 2013 Dec;9(12):e1003761. doi: 10.1371/journal.ppat.1003761. Epub 2013 Dec 5.

PMID: 24348242 [PubMed - in process]

Select item 24348203 20.

Characterization of regional influenza seasonality patterns in china and implications for vaccination strategies: spatio-temporal modeling of surveillance data.

Yu H, Alonso WJ, Feng L, Tan Y, Shu Y, Yang W, Viboud C.

PLoS Med. 2013 Nov;10(11):e1001552. doi: 10.1371/journal.pmed.1001552. Epub 2013 Nov 19.

PMID: 24348203 [PubMed - in process]

Select item 24347985 21.

Annual report on adverse events related with vaccines use in Calabria (Italy): 2012.

Staltari O, Cilurzo F, Caroleo B, Greco A, Corasaniti F, Genovesi MA, Gallelli L.

J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S61-5. doi: 10.4103/0976- 500X.120951.

PMID: 24347985 [PubMed]

Select item 24347735 22.

Rapid monitoring in vaccination campaigns during emergencies: the post-earthquake campaign in Haiti.

Rainey JJ, Sugerman D, Brennan M, Cadet JR, Ernsly J, Lacapère F, Danovaro-Holliday MC, Mubalama JC, Nandy R.

Bull World Health Organ. 2013 Dec 1;91(12):957-62. doi: 10.2471/BLT.12.117044. Epub 2013 Sep 10.

PMID: 24347735 [PubMed - in process]

Select item 24347729 23.

Frequent exposure to suboptimal temperatures in vaccine cold-chain system in India: results of temperature monitoring in 10 states.

Murhekar MV, Dutta S, Kapoor AN, Bitragunta S, Dodum R, Ghosh P, Swamy KK, Mukhopadhyay K, Ningombam S, Parmar K, Ravishankar D, Singh B, Singh V, Sisodiya R, Subramanian R, Takum T.

Bull World Health Organ. 2013 Dec 1;91(12):906-13. doi: 10.2471/BLT.13.119974. Epub 2013 Sep 9.

PMID: 24347729 [PubMed - in process]

Select item 24347591 24.

HPV knowledge and vaccine acceptability in Appalachian Tennessee and Kentucky, USA.

Tiggelaar SM, Rafalski M, Davidson MA, Hu Y, Burnett L.

J Fam Plann Reprod Health Care. 2014 Jan;40(1):75-6. doi: 10.1136/jfprhc-2013- 100697. No abstract available.

PMID: 24347591 [PubMed - in process]

Select item 24347574 25.

Childhood vaccination coverage by ethnicity within London between 2006/2007 and 2010/2011.

Wagner KS, van Wijgerden JC, Andrews N, Goulden K, White JM.

Arch Dis Child. 2013 Dec 17. doi: 10.1136/archdischild-2013-304388. [Epub ahead of print]

PMID: 24347574 [PubMed - as supplied by publisher]

Select item 24347337 26.

Myocarditis with Hypotonic-Hyporesponsive Episode after Multiple Vaccination.

Ece I, Uner A, Balli S, Kibar AE.

Indian J Pediatr. 2013 Dec 19. [Epub ahead of print] No abstract available.

PMID: 24347337 [PubMed - as supplied by publisher]

Select item 24347238 27.

Bioengineering virus-like particles as vaccines.

Lua LH, Connors NK, Sainsbury F, Chuan YP, Wibowo N, Middelberg AP.

Biotechnol Bioeng. 2013 Nov 20. doi: 10.1002/bit.25159. [Epub ahead of print]

PMID: 24347238 [PubMed - as supplied by publisher]

Select item 24346686 28.

The future of cancer research: Prevention, screening, vaccines, and tumor-specific drug combos.

Blanck G.

Hum Vaccin Immunother. 2013 Dec 17;10(3). [Epub ahead of print]

PMID: 24346686 [PubMed - as supplied by publisher]

Select item 24346613 29.

Chitosan: A promising safe and immune-enhancing adjuvant for intranasal vaccines.

Smith A, Perelman M, Hinchcliffe M.

Hum Vaccin Immunother. 2013 Dec 17;10(3). [Epub ahead of print] Review.

PMID: 24346613 [PubMed - as supplied by publisher]

Select item 24346604 30.

Measles Vaccine Strain From the Skin Rash of a DiGeorge Patient Receiving Tumor Necrosis Factor Inhibitor.

Iroh Tam PY, Hanisch BR, Klammer K, Devries AS.

Pediatr Infect Dis J. 2014 Jan;33(1):117. doi: 10.1097/INF.0000000000000073. No abstract available.

PMID: 24346604 [PubMed - in process]

Select item 24346596 31.

Safety and Immunogenicity of a Toddler Dose Following an Infant Series of a Hexavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b, Hepatitis B Vaccine Administered Concurrently or at Separate Visits With a Heptavalent Pneumococcal Conjugate Vaccine.

Halperin SA, Tapiéro B, Dionne M, Meekison W, Diaz-Mitoma F, Zickler P, Rubin E, Embree J, Bhuyan P, Lee A, Li M, Tomovici A.

Pediatr Infect Dis J. 2014 Jan;33(1):73-80. doi: 10.1097/01.inf.0000437806.76221.20.

PMID: 24346596 [PubMed - in process]

Select item 24346368 32.

Flu vaccines.

[No authors listed]

Nursing. 2014 Jan;44(1):39. doi: 10.1097/01.NURSE.0000438708.74603.bc. No abstract available.

PMID: 24346368 [PubMed - in process]

Select item 24345916 33.

Molecular adjuvant interleukin-33 enhances the antifertility effect of Lagurus lagurus zona pellucida 3 DNA vaccine administered by the mucosal route. 13

Tu YX, Li XP, Kadir Z, Zhang FC.

Braz J Med Biol Res. 2013 Dec 10;46(12):1064-1073. [Epub ahead of print]

PMID: 24345916 [PubMed - as supplied by publisher]

Select item 24345411 34.

Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C).

Cao Y, Lu Z, Li D, Fan P, Sun P, Bao H, Fu Y, Li P, Bai X, Chen Y, Xie B, Liu Z.

Vet Microbiol. 2013 Nov 28. pii: S0378-1135(13)00546-4. doi: 10.1016/j.vetmic.2013.11.023. [Epub ahead of print]

PMID: 24345411 [PubMed - as supplied by publisher]

Select item 24344660 35.

Influenza virus vaccine reduces risk of ischemic events: time for a large-scale randomized trial?

Macintyre RC, Heywood AE, Kovoor P.

Future Cardiol. 2014 Jan;10(1):35-7. doi: 10.2217/fca.13.95. No abstract available.

PMID: 24344660 [PubMed - in process]

Select item 24344540 36.

HPV vaccine could also prevent oropharyngeal cancer, says IARC.

[No authors listed]

Cent Eur J Public Health. 2013 Sep;21(3):149, 154. No abstract available.

PMID: 24344540 [PubMed - in process]

Select item 24344259 37.

Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines.

Lu Y, Welsh JP, Swartz JR.

Proc Natl Acad Sci U S A. 2013 Dec 16. [Epub ahead of print]

PMID: 24344259 [PubMed - as supplied by publisher]

Related citations

Select item 24344141 38.

Pneumococcal Serotype Diversity among Adults in Various Countries, Influenced by Pediatric Pneumococcal Vaccination Uptake.

Grabenstein JD, Weber DJ.

Clin Infect Dis. 2013 Dec 15. [Epub ahead of print]

PMID: 24344141 [PubMed - as supplied by publisher]

Related citations

Select item 24343886 39.

Determinants and Coverage of Vaccination in Children in Western Kenya from a 2003 Cross-Sectional Survey.

Calhoun LM, van Eijk AM, Lindblade KA, Odhiambo FO, Wilson ML, Winterbauer E, Slutsker L, Hamel MJ.

Am J Trop Med Hyg. 2013 Dec 16. [Epub ahead of print]

PMID: 24343886 [PubMed - as supplied by publisher]

Related citations

Select item 24343789 40.

Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine.

Sawaengsak C, Mori Y, Yamanishi K, Mitrevej A, Sinchaipanid N.

AAPS PharmSciTech. 2013 Dec 17. [Epub ahead of print]

PMID: 24343789 [PubMed - as supplied by publisher]

Related citations

Select item 24343645 41.

Janus Kinase 3 Activity is Necessary for the Phosphorylation of Cytosolic Phospholipase A2 and Prostaglandin E2 Synthesis by Macrophages infected with Francisella tularensis Live Vaccine Strain.

Brummett AM, Navratil AR, Bryan JD, Woolard MD.

Infect Immun. 2013 Dec 16. [Epub ahead of print]

PMID: 24343645 [PubMed - as supplied by publisher]

Related citations

Select item 24343624 42.

Preparing for Safety Monitoring After Rotavirus Vaccine Implementation: A Retrospective Review of Intussusception Cases among Children at a Large Teaching Hospital in Rwanda, 2009-2012.

Ngendahayo E, Bonane A, Ntakiyiruta G, Munyanshongore A, Muganga N, Bikoroti J, Mwenda JM, Tate JE, Ngabo F.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S99-S103. doi: 10.1097/INF.0000000000000093.

PMID: 24343624 [PubMed - in process]

Related citations

Select item 24343623 43.

Intussusception incidence rates in 9 zambian hospitals, 2007-2011: prerotavirus vaccine introduction.

Mpabalwani EM, Chitambala P, Chibumbya JN, Matapo B, Mutambo H, Mwenda JM, Babaniyi O, Munkonge L.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S94-8. doi: 10.1097/INF.0000000000000055.

PMID: 24343623 [PubMed - in process]

Related citations 16

Select item 24343621 44.

Can Routinely Collected National Data on Childhood Morbidity and Mortality from Diarrhea be Used to Monitor Health Impact of Rotavirus Vaccination in Africa?: Examination of Pre-Vaccine Baseline Data from Rwanda.

Ngabo F, Gatera M, Karema C, Donnen P, Lepage P, Parashar UD, Tate JE, Mwenda JM, Rugambwa C, Binagwaho A.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S89-93. doi: 10.1097/INF.0000000000000054.

PMID: 24343621 [PubMed - in process]

Related citations

Select item 24343609 45.

Baseline burden of rotavirus disease in Sudan to monitor the impact of vaccination.

Mustafa A, Makki A, Siddig O, Haithami S, Teleb N, Trivedi T, Parashar U, Patel M.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S23-7. doi: 10.1097/INF.0000000000000095.

PMID: 24343609 [PubMed - in process]

Related citations

Select item 24343605 46.

Preparing for the Scale-up of Rotavirus Vaccine Introduction in Africa: Establishing Surveillance Platforms to Monitor Disease Burden and Vaccine Impact.

Mwenda JM, Tate JE, Steele AD, Parashar UD.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S1-5. doi: 10.1097/INF.0000000000000132.

PMID: 24343605 [PubMed - in process]

Related citations

Select item 24343409 47.

HPV vaccination reduced cytologic abnormalities compared with control vaccination in young women.

Budenholzer B.

Ann Intern Med. 2013 Dec 17;159(12):JC4. doi: 10.7326/0003-4819-159-12- 201312170-02004. No abstract available.

PMID: 24343409 [PubMed - in process]

Related citations

Select item 24343228 48.

PPD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8+ T cells induced by melanoma vaccines.

Fourcade J, Sun Z, Pagliano O, Chauvin JM, Wang H, Sander C, Janjic B, Tarhini AA, Tawbi HA, Kirkwood JM, Moschos S, Guillaume P, Luescher IF, Krieg A, Anderson AC, Kuchroo VK, Zarour HM.

Cancer Res. 2013 Dec 16. [Epub ahead of print]

PMID: 24343228 [PubMed - as supplied by publisher]

Related citations

Select item 24343049 49.

Effectiveness of 2012-2013 influenza vaccine against influenza-like illness in general population: Estimation in a French web-based cohort.

Debin M, Colizza V, Blanchon T, Hanslik T, Turbelin C, Falchi A.

Hum Vaccin Immunother. 2013 Dec 16;10(3). [Epub ahead of print]

PMID: 24343049 [PubMed - as supplied by publisher]

Related citations

Select item 24342988 50.

Influenza vaccination effectiveness, unmeasured confounding and immunomodulatory treatment.

Fedson DS.

J Infect Dis. 2013 Dec 15. [Epub ahead of print] No abstract available.

PMID: 24342988 [PubMed - as supplied by publisher]

Related citations

Select item 24342916 51.

Narcolepsy and A(H1N1)pdm09 vaccination: Shaping the research on the observed signal. van der Most R, Van Mechelen M, Destexhe E, Wettendorff M, Hanon E.

Hum Vaccin Immunother. 2013 Dec 16;10(3). [Epub ahead of print]

PMID: 24342916 [PubMed - as supplied by publisher]

Related citations

Select item 24342877 52.

Real-time RT-PCR assays to differentiate wild-type group A rotavirus strains from Rotarix^® and RotaTeq^® vaccine strains in stool samples.

Gautam R, Esona MD, Mijatovic-Rustempasic S, Ian Tam K, Gentsch JR, Bowen MD.

Hum Vaccin Immunother. 2013 Dec 16;10(3). [Epub ahead of print]

PMID: 24342877 [PubMed - as supplied by publisher]

Related citations

Select item 24342722 53.

Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan.

Jiang T, Singh B, Li HS, Kim YK, Kang SK, Nah JW, Choi YJ, Cho CS.

Biomaterials. 2013 Dec 13. pii: S0142-9612(13)01439-7. doi: 10.1016/j.biomaterials.2013.11.073. [Epub ahead of print]

PMID:

24342722 [PubMed - as supplied by publisher]

Related citations

Select item 24342572 54.

Transfer of serum and cells from Yersinia ruckeri vaccinated doubled-haploid Hot Creek Rainbow trout into outcross F1 progeny elucidates mechanisms of vaccine- induced protection.

Evenhuis JP, Wiens GD, Wheeler P, Welch TJ, Lapatra SE, Thorgaard GH.

Dev Comp Immunol. 2013 Dec 13. pii: S0145-305X(13)00351-0. doi: 10.1016/j.dci.2013.12.004. [Epub ahead of print]

PMID: 24342572 [PubMed - as supplied by publisher]

Related citations

Select item 24342254 55.

Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stability.

Gonçalves VM, Dias WO, Ivana CB, Liberman C, Sbrogio-Almeida ME, Silva EP, Cardoso CP, Alderson M, Robertson G, Maisonneuve JF, Tate A, Anderson P, Malley R, Fratelli F, Leite LC.

Vaccine. 2013 Dec 13. pii: S0264-410X(13)01693-9. doi: 10.1016/j.vaccine.2013.10.091. [Epub ahead of print]

PMID: 24342254 [PubMed - as supplied by publisher]

Related citations

Select item 24342253 56.

Accuracy of traditional and novel serology tests for predicting cross-protection in foot- and-mouth disease vaccinated cattle.

Brito BP, Perez AM, Capozzo AV.

Vaccine. 2013 Dec 13. pii: S0264-410X(13)01705-2. doi: 10.1016/j.vaccine.2013.12.007. [Epub ahead of print]

PMID: 24342253 20

[PubMed - as supplied by publisher]

Related citations

Select item 24342252 57.

Randomized controlled trial of two dosing schedules for human papillomavirus vaccination among college age males.

Lin CJ, Zimmerman RK, Nowalk MP, Huang HH, Raviotta JM.

Vaccine. 2013 Dec 13. pii: S0264-410X(13)01691-5. doi: 10.1016/j.vaccine.2013.11.098. [Epub ahead of print]

PMID: 24342252 [PubMed - as supplied by publisher]

Related citations

Select item 24342249 58.

Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.

Zuccotti G, Mameli C, Daprai L, Garlaschi ML, Dilillo D, Bedogni G, Faccini M, Gramegna M, Torresani E; For the PneuMi Study Group (PMSG).

Vaccine. 2013 Dec 13. pii: S0264-410X(13)01697-6. doi: 10.1016/j.vaccine.2013.12.003. [Epub ahead of print]

PMID: 24342249 [PubMed - as supplied by publisher]

Related citations

Select item 24342248 59.

Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains.

Jang YH, Lee EY, Byun YH, Jung EJ, Lee YJ, Lee YH, Lee KH, Lee J, Seong BL.

Vaccine. 2013 Dec 13. pii: S0264-410X(13)01694-0. doi: 10.1016/j.vaccine.2013.12.002. [Epub ahead of print]

PMID: 24342248 [PubMed - as supplied by publisher]

Related citations

Select item 24342246 60.

Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.

Pakkanen SH, Kantele JM, Herzog C, Kantele A.

Vaccine. 2013 Dec 13. pii: S0264-410X(13)01690-3. doi: 10.1016/j.vaccine.2013.12.001. [Epub ahead of print]

PMID: 24342246 [PubMed - as supplied by publisher]

Related citations

Select item 24342164 61.

Intramuscular electroporation of a P1A-encoding plasmid vaccine delays P815 mastocytoma growth.

Vandermeulen G, Uyttenhove C, De Plaen E, Van den Eynde BJ, Préat V.

Bioelectrochemistry. 2013 Dec 1. pii: S1567-5394(13)00131-X. doi: 10.1016/j.bioelechem.2013.11.002. [Epub ahead of print]

PMID: 24342164 [PubMed - as supplied by publisher]

Related citations

Select item 24342026 62.

The receptor binding domain of MERS-CoV: The dawn of vaccine and treatment development.

Zhou N, Zhang Y, Zhang JC, Feng L, Bao JK.

J Formos Med Assoc. 2013 Dec 13. pii: S0929-6646(13)00402-6. doi: 10.1016/j.jfma.2013.11.006. [Epub ahead of print]

PMID: 24342026 [PubMed - as supplied by publisher]

Related citations

Select item 24341884 63.

Broadly neutralizing antibodies and the promise of universal vaccines: where are we now?

Hefferon KL.

Immunotherapy. 2014 Jan;6(1):51-7. doi: 10.2217/imt.13.150.

PMID: 24341884 [PubMed - in process]

Related citations

Select item 24341882 64.

Ovarian cancer: designing effective vaccines and specific diagnostic tools.

Spinosa JP, Kanduc D.

Immunotherapy. 2014 Jan;6(1):35-41. doi: 10.2217/imt.13.144.

PMID: 24341882 [PubMed - in process]

Related citations

Select item 24341659 65.

Effect of levamisole supplementation on tetanus vaccination response rates in haemodialysis patients: A randomized double-blind placebo-controlled trial.

Fallahzadeh MK, Sajjadi S, Singh N, Khajeh M, Sagheb MM.

Nephrology (Carlton). 2014 Jan;19(1):27-31. doi: 10.1111/nep.12158.

PMID: 24341659 [PubMed - in process]

Related citations

Select item 24341480 66.

Measles in a previously vaccinated human immunodeficiency virus-positive adult.

Mahil SK, Fleming J, Robson A, Sarkany R.

Clin Exp Dermatol. 2014 Jan;39(1):117-8. doi: 10.1111/ced.12238. Epub 2013 Nov 7. No abstract available.

PMID: 24341480 [PubMed - in process]

Related citations

Select item 24341406 67.

Why parents refuse childhood vaccination: a qualitative study using online focus groups.

Harmsen IA, Mollema L, Ruiter RA, Paulussen TG, de Melker HE, Kok G.

BMC Public Health. 2013 Dec 16;13(1):1183. [Epub ahead of print]

PMID: 24341406 [PubMed - as supplied by publisher]

Related citations

Select item 24341215 68.

[Morphofunctional evaluation of the state of cells of APUD-system biomodel during anti-plague vaccine process].

[No authors listed]

Zh Mikrobiol Epidemiol Immunobiol. 2013 Jul-Aug;(4):49-55. Russian.

PMID: 24341215 [PubMed - in process]

Related citations

Select item 24339853 69.

Correction: Augmenting Transport versus Increasing Cold Storage to Improve Vaccine Supply Chains.

Haidari LA, Connor DL, Wateska AR, Brown ST, Mueller LE, Norman BA, Schmitz MM, Paul P, Rajgopal J, Welling JS, Leonard J, Chen SI, Lee BY.

PLoS One. 2013 Dec 10;8(12). doi: 10.1371/annotation/b428dad2-e829-4289-acae- c44369d55a80.

PMID:

24339853 [PubMed - as supplied by publisher]

Related citations

Select item 24339589 70.

The neuroprotective effect of immune serum of adeno-associated virus vaccine containing Aβ1-15 gene on amyloid toxicity.

Liu LY, Ma YY, Yang T, Li X, Li W.

Ann Indian Acad Neurol. 2013 Oct;16(4):603-8. doi: 10.4103/0972-2327.120489.

PMID: 24339589 [PubMed]

Related citations

Select item 24339395 71.

Effect of methotrexate, anti-TNFα and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: A systematic review and meta-analysis.

Hua C, Barnetche T, Combe B, Morel J.

Arthritis Care Res (Hoboken). 2013 Dec 10. doi: 10.1002/acr.22246. [Epub ahead of print]

PMID: 24339395 [PubMed - as supplied by publisher]

Related citations

Select item 24339387 72.

Whole Blood Cells Loaded with Messenger RNA as an Anti-Tumor Vaccine.

Phua KK, Boczkowski D, Dannull J, Pruitt S, Leong KW, Nair SK.

Adv Healthc Mater. 2013 Dec 16. doi: 10.1002/adhm.201300512. [Epub ahead of print]

PMID: 24339387 [PubMed - as supplied by publisher]

Related citations

Select item 24339297 73.

The immunogenicity of a single dose of hepatitis a virus vaccines (havrix® and epaxal®) in korean young adults.

Lim J, Song YJ, Park WS, Sohn H, Lee MS, Shin DH, Kim CB, Kim H, Oh GJ, Ki M.

Yonsei Med J. 2014 Jan 1;55(1):126-31. doi: 10.3349/ymj.2014.55.1.126.

PMID: 24339297 [PubMed - in process]

Related citations

Select item 24338683 74.

A novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice.

Saif JM, Vadakekolathu J, Rane SS, McDonald D, Ahmad M, Mathieu M, Pockley AG, Durrant L, Metheringham R, Rees RC, McArdle S.

Eur J Immunol. 2013 Dec 12. doi: 10.1002/eji.201343863. [Epub ahead of print]

PMID: 24338683 [PubMed - as supplied by publisher]

Related citations

Select item 24338330 75.

Prime-boost vaccination with plasmid DNA followed by recombinant vaccinia virus expressing BgGARP induced a partial protective immunity to inhibit Babesia gibsoni proliferation in dogs.

Cao S, Mousa AA, Aboge GO, Kamyingkird K, Zhou M, Moumouni PF, Terkawi MA, Masatani T, Nishikawa Y, Suzuki H, Fukumoto S, Xuan X.

Acta Parasitol. 2013 Dec;58(4):619-23. doi: 10.2478/s11686-013-0183-1. Epub 2013 Dec 13.

PMID: 24338330 [PubMed - in process]

Related citations

Select item 24338083 76.

A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program.

O'Ryan M, Stoddard J, Toneatto D, Wassil J, Dull PM.

Drugs. 2013 Dec 12. [Epub ahead of print]

PMID: 24338083 [PubMed - as supplied by publisher]

Related citations

Select item 24337749 77.

KLRG1 Impairs CD4+ T Cell Responses via p16ink4a and p27kip1 Pathways: Role in Hepatitis B Vaccine Failure in Individuals with Hepatitis C Virus Infection.

Shi L, Wang JM, Ren JP, Cheng YQ, Ying RS, Wu XY, Lin SM, Griffin JW, Li GY, Moorman JP, Yao ZQ.

J Immunol. 2013 Dec 13. [Epub ahead of print]

PMID: 24337749 [PubMed - as supplied by publisher]

Related citations

Select item 24337381 78.

Novel Mechanisms Underlying the Immediate and Transient Global Tolerization of Splenic Dendritic Cells after Vaccination with a Self-Antigen.

Farkas AM, Finn OJ.

J Immunol. 2013 Dec 11. [Epub ahead of print]

PMID: 24337381 [PubMed - as supplied by publisher]

Related citations

Select item 24336502 79.

Viral diseases: Zeroing in on RSV vaccine design.

Crunkhorn S.

Nat Rev Drug Discov. 2013 Dec 13. doi: 10.1038/nrd4207. [Epub ahead of print] No abstract available.

PMID: 24336502 [PubMed - as supplied by publisher]

Related citations

Select item 24336457 80.

Dietary Wolfberry Supplementation Enhances the Protective Effect of Flu Vaccine against Influenza Challenge in Aged Mice.

Du X, Wang J, Niu X, Smith D, Wu D, Meydani SN.

J Nutr. 2013 Dec 11. [Epub ahead of print]

PMID: 24336457 [PubMed - as supplied by publisher]

Related citations

Select item 24336226 81.

Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.

Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, Kasturi S, Carlone GM, Quinn C, Chaussabel D, Palucka AK, Mulligan MJ, Ahmed R, Stephens DS, Nakaya HI, Pulendran B.

Nat Immunol. 2013 Dec 15. doi: 10.1038/ni.2789. [Epub ahead of print]

PMID: 24336226 [PubMed - as supplied by publisher]

Related citations

Select item 24336179 82.

The value of vaccines.

Hofer U.

Nat Rev Microbiol. 2013 Dec 16;12(1):6. doi: 10.1038/nrmicro3195. No abstract available.

PMID:

24336179 [PubMed - in process]

Related citations

Select item 24336132 83.

Seasonal influenza vaccination coverage among women who delivered a live-born infant - 21 States and new york city, 2009-10 and 2010-11 influenza seasons.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 Dec 13;62(49):1001-4.

PMID: 24336132 [PubMed - in process]

Related citations

Select item 24336131 84.

Estimated influenza illnesses and hospitalizations averted by influenza vaccination - United States, 2012-13 influenza season.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 Dec 13;62(49):997-1000.

PMID: 24336131 [PubMed - in process]

Related citations

Select item 24336060 85.

Methods for a systematic review of pneumococcal conjugate vaccine dosing schedules.

Loo JD, Conklin L, Deloria Knoll M, Fleming-Dutra KE, Park DE, Kirk J, Johnson TS, Goldblatt D, O'Brien KL, Whitney CG.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S182-7. doi: 10.1097/INF.0000000000000085.

PMID: 24336060 [PubMed - in process]

Related citations

Select item 24336059 86.

Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers.

Whitney CG, Goldblatt D, O'Brien KL.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S172-81. doi: 10.1097/INF.0000000000000076.

PMID: 24336059 [PubMed - in process]

Related citations

Select item 24336058 87.

Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization.

Loo JD, Conklin L, Fleming-Dutra KE, Knoll MD, Park DE, Kirk J, Goldblatt D, O'Brien KL, Whitney CG.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S161-71. doi: 10.1097/INF.0000000000000084.

PMID: 24336058 [PubMed - in process]

Related citations

Select item 24336057 88.

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Nasopharyngeal Carriage.

Fleming-Dutra KE, Conklin L, Loo JD, Knoll MD, Park DE, Kirk J, Goldblatt D, Whitney CG, O'Brien KL.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S152-60. doi: 10.1097/INF.0000000000000083.

PMID: 24336057 [PubMed - in process]

Related citations

Select item 24336056 89. 30

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia.

Loo JD, Conklin L, Fleming-Dutra KE, Deloria Knoll M, Park DE, Kirk J, Goldblatt D, O'Brien KL, Whitney CG.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S140-51. doi: 10.1097/INF.0000000000000082.

PMID: 24336056 [PubMed - in process]

Related citations

Select item 24336055 90.

The differential impact of coadministered vaccines, geographic region, vaccine product and other covariates on pneumococcal conjugate vaccine immunogenicity.

Park DE, Johnson TS, Nonyane BA, Chandir S, Conklin L, Fleming-Dutra KE, Loo JD, Goldblatt D, Whitney CG, O'Brien KL, Deloria Knoll M.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S130-9. doi: 10.1097/INF.0000000000000081.

PMID: 24336055 [PubMed - in process]

Related citations

Select item 24336054 91.

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity.

Deloria Knoll M, Park DE, Johnson TS, Chandir S, Nonyane BA, Conklin L, Fleming-Dutra KE, Loo JD, Goldblatt D, Whitney CG, O'Brien KL.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S119-29. doi: 10.1097/INF.0000000000000079.

PMID: 24336054 [PubMed - in process]

Related citations

Select item 24336053 92.

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Invasive Pneumococcal Disease Among Young Children.

Conklin L, Loo JD, Kirk J, Fleming-Dutra KE, Deloria Knoll M, Park DE, Goldblatt D, O'Brien KL, Whitney CG.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S109-18. doi: 10.1097/INF.0000000000000078.

PMID: 24336053 [PubMed - in process]

Related citations

Select item 24336052 93.

Why do we need a systematic review of pneumococcal conjugate vaccine dosing schedules?

O'Brien KL, Goldblatt D, Whitney CG.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S107-8. doi: 10.1097/INF.0000000000000075. No abstract available.

PMID: 24336052 [PubMed - in process]

Related citations

Select item 24335963 94.

Safety of second-generation rotavirus vaccines, intussusception.

Vázquez M.

Curr Opin Pediatr. 2013 Dec 11. [Epub ahead of print]

PMID: 24335963 [PubMed - as supplied by publisher]

Related citations

Select item 24335743 95.

Human papillomavirus vaccine administration among medicaid providers who consistently recommended vaccination.

Malo TL, Staras SA, Bynum SA, Giuliano AR, Shenkman EA, Vadaparampil ST.

Sex Transm Dis. 2014 Jan;41(1):24-8. doi: 10.1097/OLQ.0000000000000064.

PMID: 24335743 [PubMed - in process]

Related citations

Select item 24335700 96.

Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial.

Bloch O, Crane CA, Fuks Y, Kaur R, Aghi MK, Berger MS, Butowski NA, Chang SM, Clarke JL, McDermott MW, Prados MD, Sloan AE, Bruce JN, Parsa AT.

Neuro Oncol. 2013 Dec 12. [Epub ahead of print]

PMID: 24335700 [PubMed - as supplied by publisher]

Related citations

Select item 24335292 97.

Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.

Zapata JC, Goicochea M, Nadai Y, Eyzaguirre LM, Carr JK, Tallon LJ, Sadzewicz L, Myers G, Fraser CM, Su Q, Djavani M, Lukashevich IS, Salvato MS.

J Virol. 2013 Dec 11. [Epub ahead of print]

PMID: 24335292 [PubMed - as supplied by publisher]

Related citations

Select item 24334943 98.

Hepatitis B seroprevalence in children and women and the impact of the hepatitis B vaccination program in the Black Sea Region of Turkey.

Karatekin G, Kilinc M, Gulcan Oksuz B, Igde M.

J Infect Dev Ctries. 2013 Dec 15;7(12):960-5. doi: 10.3855/jidc.4102.

PMID: 24334943 [PubMed - in process]

Related citations

Select item 24334689 99.

Phase III clinical trials comparing the immunogenicity and safety of Vero cell-derived Japanese encephalitis vaccine ENCEVAC(R) with those of mouse brain-derived vaccine using the Beijing-1 strain.

Miyazaki C, Okada K, Ozaki T, Hirose M, Iribe K, Yokote H, Ishikawa Y, Togashi T, Ueda K.

Clin Vaccine Immunol. 2013 Dec 11. [Epub ahead of print]

PMID: 24334689 [PubMed - as supplied by publisher]

Related citations

Select item 24334685 100.

Ocular immune responses in steers following intranasal vaccination with recombinant Moraxella bovis cytotoxin adjuvanted with polyacrylic acid.

Angelos JA, Edman JM, Chigerwe M.

Clin Vaccine Immunol. 2013 Dec 11. [Epub ahead of print]

PMID: 24334685 [PubMed - as supplied by publisher]

Related citations

Select item 24333835 101.

Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation.

Calvo-Pinilla E, de la Poza F, Gubbins S, Mertens PP, Ortego J, Castillo-Olivares J.

Virus Res. 2013 Dec 12. pii: S0168-1702(13)00431-0. doi: 10.1016/j.virusres.2013.12.002. [Epub ahead of print]

PMID: 24333835 [PubMed - as supplied by publisher]

Related citations

Select item 24333518 102.

Fusion of HPV L1 into Shigella surface IcsA: a new approach in developing live attenuated Shigella-HPV vaccine.

Xu D, Wang D, Yang X, Cao M, Yu J, Wang Y.

Antiviral Res. 2013 Dec 12. pii: S0166-3542(13)00361-6. doi: 10.1016/j.antiviral.2013.12.003. [Epub ahead of print]

PMID: 24333518 [PubMed - as supplied by publisher]

Related citations

Select item 24333345 103.

A mucosal adjuvant for the inactivated poliovirus vaccine.

Steil BP, Jorquera P, Westdijk J, Bakker WA, Johnston RE, Barro M.

Vaccine. 2013 Dec 12. pii: S0264-410X(13)01696-4. doi: 10.1016/j.vaccine.2013.11.101. [Epub ahead of print]

PMID: 24333345 [PubMed - as supplied by publisher]

Related citations

Select item 24333344 104.

Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza.

Rinaldi S, Zangari P, Cotugno N, Manno EC, Brolatti N, Castrucci MR, Donatelli I, Rossi P, Palma P, Cagigi A.

Vaccine. 2013 Dec 12. pii: S0264-410X(13)01706-4. doi: 10.1016/j.vaccine.2013.12.008. [Epub ahead of print]

PMID: 24333344 [PubMed - as supplied by publisher]

Related citations

Select item 24333120 105.

Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients.

Dhédin N, Krivine A, Le Corre N, Mallet A, Lioure B, Bay JO, Rubio MT, Agape P, Thiébaut A, Le Goff J, Autran B, Ribaud P.

Vaccine. 2013 Dec 11. pii: S0264-410X(13)01662-9. doi: 10.1016/j.vaccine.2013.11.073. [Epub ahead of print]

PMID: 24333120 [PubMed - as supplied by publisher]

Related citations

Select item 24332702 106.

Systemic and local immune response in pigs intradermally and intramuscularly injected with inactivated Mycoplasma hyopneumoniae vaccines.

Martelli P, Saleri R, Cavalli V, De Angelis E, Ferrari L, Benetti M, Ferrarini G, Merialdi G, Borghetti P.

Vet Microbiol. 2013 Nov 28. pii: S0378-1135(13)00548-8. doi: 10.1016/j.vetmic.2013.11.025. [Epub ahead of print]

PMID: 24332702 [PubMed - as supplied by publisher]

Related citations

Select item 24332642 107.

Preclinical and clinical development of DNA vaccines for prostate cancer.

Teja Colluru V, Johnson LE, Olson BM, McNeel DG.

Urol Oncol. 2013 Dec 11. pii: S1078-1439(13)00387-6. doi: 10.1016/j.urolonc.2013.09.014. [Epub ahead of print]

PMID: 24332642 [PubMed - as supplied by publisher]

Related citations

Select item 24332501 108.

The 6th International Veterinary Vaccines and Diagnostic Conference (6th IVVDC).

Adler B, Meeusen E.

Vet Immunol Immunopathol. 2013 Nov 28. pii: S0165-2427(13)00310-3. doi: 10.1016/j.vetimm.2013.11.004. [Epub ahead of print] No abstract available.

PMID: 24332501 [PubMed - as supplied by publisher]

Related citations

Select item 24332298 109.

Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in central and eastern europe.

Poljak M, Seme K, Maver PJ, Kocjan BJ, Cuschieri KS, Rogovskaya SI, Arbyn M, Syrjänen S.

Vaccine. 2013 Dec 31;31 Suppl 7:H59-70. doi: 10.1016/j.vaccine.2013.03.029.

PMID: 24332298 [PubMed - in process]

Related citations

Select item 24332297 110.

Human Papillomavirus Prevalence and Type-Distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in Russian Federation, the Western Countries of the former Soviet Union, Caucasus Region and Central Asia.

Rogovskaya SI, Shabalova IP, Mikheeva IV, Minkina GN, Podzolkova NM, Shipulina OY, Sultanov SN, Kosenko IA, Brotons M, Buttmann N, Dartell M, Arbyn M, Syrjänen S, Poljak M.

Vaccine. 2013 Dec 31;31 Suppl 7:H46-58. doi: 10.1016/j.vaccine.2013.06.043.

PMID: 24332297 [PubMed - in process]

Related citations

Select item 24332180 111.

[Basal cell carcinoma in a smallpox vaccination scar.]

Kluger N, Dissard C.

Presse Med. 2013 Dec 10. pii: S0755-4982(13)00816-6. doi: 10.1016/j.lpm.2013.06.022. [Epub ahead of print] French. No abstract available.

PMID: 24332180 [PubMed - as supplied by publisher]

Related citations

Select item 24331821 112.

Prospects and challenges in the introduction of human papillomavirus vaccines in the extended middle East and north Africa region.

Jumaan AO, Ghanem S, Taher J, Braikat M, Awaidy SA, Dbaibo GS.

Vaccine. 2013 Dec 30;31 Suppl 6:G58-64. doi: 10.1016/j.vaccine.2012.06.097.

PMID: 24331821 [PubMed - in process]

Related citations

Select item 24331747 113.

Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-saharan Africa.

Sankaranarayanan R, Anorlu R, Sangwa-Lugoma G, Denny LA.

Vaccine. 2013 Dec 29;31 Suppl 5:F47-52. doi: 10.1016/j.vaccine.2012.06.066.

PMID: 24331747 [PubMed - in process]

Related citations

Select item 24331381 114.

Transcutaneous yellow fever vaccination of subjects with or without atopic dermatitis.

Slifka MK, Leung DY, Hammarlund E, Raué HP, Simpson EL, Tofte S, Baig-Lewis S, David G, Lynn H, Woolson R, Hata T, Milgrom H, Hanifin J.

J Allergy Clin Immunol. 2013 Dec 9. pii: S0091-6749(13)01698-9. doi: 10.1016/j.jaci.2013.10.037. [Epub ahead of print]

PMID: 24331381

[PubMed - as supplied by publisher]

Related citations

Select item 24331023 115.

The impact of hepatitis B vaccine in China and in the China GAVI Project.

Hadler SC, Fuqiang C, Averhoff F, Taylor T, Fuzhen W, Li L, Xiaofeng L, Weizhong Y.

Vaccine. 2013 Dec 27;31 Suppl 9:J66-72. doi: 10.1016/j.vaccine.2013.03.043.

PMID: 24331023 [PubMed - in process]

Related citations

Select item 24331021 116.

Improving hepatitis B vaccine timely birth dose coverage: Lessons from five demonstration projects in China, 2005-2009.

Hutin Y, Hennessey K, Cairns L, Zhang Y, Li H, Zhao L, Cui F, Lee L, Tan V, Takashima Y, Zuo S, Hadler S.

Vaccine. 2013 Dec 27;31 Suppl 9:J49-55. doi: 10.1016/j.vaccine.2013.03.025.

PMID: 24331021 [PubMed - in process]

Related citations

Select item 24331017 117.

Preventing hepatitis B though universal vaccination: Reduction of inequalities through the GAVI China project.

Cui F, Liang X, Gong X, Chen Y, Wang F, Zheng H, Wu Z, Miao N, Hadler SC, Hutin YJ, Luo H, Yang W.

Vaccine. 2013 Dec 27;31 Suppl 9:J29-35. doi: 10.1016/j.vaccine.2012.07.048.

PMID: 24331017 [PubMed - in process]

Related citations

Select item 24330942 118.

Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013.

Murti M, Krajden M, Petric M, Hiebert J, Hemming F, Hefford B, Bigham M, Van Buynder P.

Euro Surveill. 2013 Dec 5;18(49). pii: 20649. No abstract available.

PMID: 24330942 [PubMed - in process]

Related citations

Select item 24330787 119.

[Tetanus prophylaxis after an injury; check the need for vaccination and immunoglobulin].

Te Wierik MJ, Hahné SJ, van Ooik PC, van Lier AM, Swaan CM.

Ned Tijdschr Geneeskd. 2013;157(0):A5906. Dutch.

PMID: 24330787 [PubMed - in process]

Related citations

Select item 24330654 120.

Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.

Mire CE, Versteeg KM, Cross RW, Agans KN, Fenton KA, Whitt MA, Geisbert TW.

Virol J. 2013 Dec 13;10(1):353. [Epub ahead of print]

PMID: 24330654 [PubMed - as supplied by publisher]

Related citations

Select item 24330575 121.

Impact of viral drift on vaccination dynamics and patterns of seasonal influenza.

Xiao Y, Moghadas SM.

BMC Infect Dis. 2013 Dec 13;13(1):589. [Epub ahead of print]

PMID: 24330575 [PubMed - as supplied by publisher]

Related citations

Select item 24330218 122.

Allergen-hybrids - next generation vaccines for Fagales pollen immunotherapy.

Pichler U, Hauser M, Hofer H, Himly M, Hoflehner E, Steiner M, Mutschlechner S, Hufnagl K, Ebner C, Mari A, Briza P, Bohle B, Wiedermann U, Ferreira F, Wallner M.

Clin Exp Allergy. 2013 Dec 11. doi: 10.1111/cea.12250. [Epub ahead of print]

PMID: 24330218 [PubMed - as supplied by publisher]

Related citations

Select item 24329865 123.

Genetic selection for resistance to mycoplasmal pneumonia of swine (MPS) in the Landrace line influences the expression of soluble factors in blood after MPS vaccine sensitization.

Shimazu T, Borjigin L, Katayama Y, Li M, Satoh T, Watanabe K, Kitazawa H, Roh SG, Aso H, Kazuo K, Suda Y, Sakuma A, Nakajo M, Suzuki K.

Anim Sci J. 2013 Dec 12. doi: 10.1111/asj.12158. [Epub ahead of print]

PMID: 24329865 [PubMed - as supplied by publisher]

Related citations

Select item 24329634 124.

Using SMS technology to verify the safety of seasonal trivalent influenza vaccine for pregnant women in real time.

Regan AK, Blyth CC, Effler PV.

Med J Aust. 2013 Dec 16;199(11):744-6. No abstract available.

PMID: 24329634 [PubMed - in process]

Related citations

Select item 24329534 125.

Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus.

Chidumayo NN, Yoshii K, Kariwa H.

Microbiol Immunol. 2013 Dec 11. doi: 10.1111/1348-0421.12122. [Epub ahead of print]

PMID: 24329534 [PubMed - as supplied by publisher]

Related citations

Select item 24329167 126.

Ready or Not: Analysis of a No-Notice Mass Vaccination Field Response in Philadelphia.

Caum J, Alles S.

Biosecur Bioterror. 2013 Dec 13. [Epub ahead of print]

PMID: 24329167 [PubMed - as supplied by publisher]

Related citations

Select item 24329002 127.

Determining the cost-effectiveness of adult pneumococcal vaccination strategies.

Smith KJ.

Expert Rev Pharmacoecon Outcomes Res. 2013 Dec 16. [Epub ahead of print]

PMID: 24329002 [PubMed - as supplied by publisher]

Related citations

Select item 24328988 128.

Personal Belief Exemptions From School Vaccination Requirements.

Diekema DS.

Annu Rev Public Health. 2013 Dec 11. [Epub ahead of print]

PMID: 24328988 [PubMed - as supplied by publisher]

Related citations

Select item 24328935 129.

Positive Inductive Effect of Swine Interleukin-4 on Immune Responses Elicited by Modified Live Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Vaccine.

Peng J, Wang J, Wu J, Du Y, Li J, Guo Z, Yu J, Xu S, Zhang Y, Sun W, Cong X, Shi J.

Viral Immunol. 2013 Dec;26(6):404-14. doi: 10.1089/vim.2013.0040.

PMID: 24328935 [PubMed - in process]

Related citations

Select item 24328855 130.

Human Papillomavirus (HPV) Risk Factors, Vaccination Patterns, and Vaccine Perceptions Among a Sample of Male College Students.

Fontenot HB, Fantasia HC, Charyk A, Sutherland MA.

J Am Coll Health. 2013 Dec 12. [Epub ahead of print]

PMID: 24328855 [PubMed - as supplied by publisher]

Related citations

Select item 24328666 131.

A Longitudinal Analysis of the Effect of Nonmedical Exemption Law and Vaccine Uptake on Vaccine-Targeted Disease Rates.

Yang YT, Debold V.

Am J Public Health. 2013 Dec 12. [Epub ahead of print]

PMID: 24328666 [PubMed - as supplied by publisher]

Related citations

Select item 24328628 132.

Mandatory Influenza Vaccination for Health Care Workers as the New Standard of Care: A Matter of Patient Safety and Nonmaleficent Practice.

Cortes-Penfield N.

Am J Public Health. 2013 Dec 12. [Epub ahead of print]

PMID: 24328628 [PubMed - as supplied by publisher]

Related citations

Select item 24328444 133.

Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in Children.

Jain VK, Rivera L, Zaman K, Espos RA Jr, Sirivichayakul C, Quiambao BP, Rivera-Medina DM, Kerdpanich P, Ceyhan M, Dinleyici EC, Cravioto A, Yunus M, Chanthavanich P, Limkittikul K, Kurugol Z, Alhan E, Caplanusi A, Durviaux S, Boutet P, Ofori-Anyinam O, Chandrasekaran V, Dbaibo G, Innis BL.

N Engl J Med. 2013 Dec 11. [Epub ahead of print]

PMID: 24328444 [PubMed - as supplied by publisher]

Related citations

Select item 24328439

134. For an Influenza Vaccine, Are Two Bs Better Than One?

Baden LR.

N Engl J Med. 2013 Dec 11. [Epub ahead of print]

PMID: 24328439 [PubMed - as supplied by publisher] Related citations

AMEDEO - Vaccines Publicaciones (16 - 12 - 2013): 19 artículos nuevos.

Vacuna Tosferina (Bordetella pertussis)

5. SICARD S, Berger F, Migliani R, Deparis X, et al. An Approach for Assessing Effectiveness of a Vaccination Campaign Against Pertussis Among Young Adults: The Example of the French Armed Forces (2007-2012). J Infect. 2013 Dec 7. pii: S0163-4453(13)00375. PubMed: www.amedeo.com/p2.php?id=24325927&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/24325927

19. LU PJ, Graitcer SB, O'Halloran A, Liang JL, et al. Tetanus, diphtheria and acellular pertussis (Tdap) vaccination among healthcare personnel-United States, 2011. Vaccine. 2013 Dec 2. pii: S0264-410X(13)01666. PubMed: www.amedeo.com/p2.php?id=24308960&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24308960

Adyuvantes

11. REED SG, Orr MT, Fox CB. Key roles of adjuvants in modern vaccines. Nat Med. 2013;19:1597-608. PubMed: www.amedeo.com/p2.php?id=24309663&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24309663

Vacunas, otras

1. RUBIN LG, Levin MJ, Ljungman P, Davies EG, et al. 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host. Clin Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=24311479&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24311479

2. MCVOY MA. Cytomegalovirus vaccines. Clin Infect Dis. 2013;57 Suppl 4:S196-9. PubMed: www.amedeo.com/p2.php?id=24257427&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24257427

3. HUNG CY, Castro-Lopez N, Cole GT. Vaccinated C57BL/6 Mice Develop Protective and Memory T Cell Response to Coccidioides posadasii Infection in the Absence of IL-10. Infect Immun. 2013. PubMed: www.amedeo.com/p2.php?id=24324188&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24324188

4. TEIXEIRA LH, Tararam CA, Lasaro MO, Camacho AG, et al. Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents.

Infect Immun. 2013. PubMed: www.amedeo.com/p2.php?id=24324178&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24324178

6. WACKER M, Wang L, Kowarik M, Dowd M, et al. Prevention of Staphylococcus aureus Infections by Glycoprotein Vaccines Synthesized in Escherichia coli. J Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=24308931&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24308931

7. HAYNES LM. Progress and Challenges in RSV Prophylaxis and Vaccine Development. J Infect Dis. 2013;208 Suppl 3:S177-83. PubMed: www.amedeo.com/p2.php?id=24265476&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24265476

8. FRESE M, Lee E, Larena M, Lim PS, et al. IRES-based attenuation of a flavivirus candidate vaccine and evaluation of IFN-beta co-expression on vaccine properties. J Virol. 2013. PubMed: www.amedeo.com/p2.php?id=24307589&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24307589

9. VAN ROMPAY KK, Hunter Z, Jayashankar K, Peabody J, et al. A Vaccine against CCR5 Protects a Subset of Macaques upon Intravaginal Challenge with SIVmac251. J Virol. 2013. PubMed: www.amedeo.com/p2.php?id=24307581&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24307581

10. Vaccination coverage among persons with asthma - United States, 2010-2011 influenza season. MMWR Morb Mortal Wkly Rep. 2013;62:973-8. PubMed: www.amedeo.com/p2.php?id=24304828&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24304828

12. Another HIV vaccine failure: where to next? Nat Med. 2013;19:1576-7. PubMed: www.amedeo.com/p2.php?id=24309655&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24309655

13. HEMMING M, Vesikari T. Detection of Rotateq(R) Vaccine-Derived Double Reassortant Rotavirus in a 7-Year-Old Child with Acute Gastroenteritis. Pediatr Infect Dis J. 2013. PubMed: www.amedeo.com/p2.php?id=24326415&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24326415

14. RAVINDRAN R, Khan N, Nakaya HI, Li S, et al. Vaccine Activation of the Nutrient Sensor GCN2 in Dendritic Cells Enhances Antigen Presentation. Science. 2013. PubMed: www.amedeo.com/p2.php?id=24310610&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24310610

15. FISKER AB, Ravn H, Rodrigues A, Ostergaard MD, et al. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau. Vaccine. 2013 Dec 7. pii: S0264-410X(13)01663. PubMed: www.amedeo.com/p2.php?id=24325827&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24325827

16. DOLL KL, Butler NS, Harty JT. CD8 T cell independent immunity after single dose infection-treatment-vaccination (ITV) against Plasmodium yoelii. Vaccine. 2013 Dec 6. pii: S0264-410X(13)01592. PubMed: www.amedeo.com/p2.php?id=24321740&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24321740

17. BROTHERTON JM, Liu B, Donovan B, Kaldor JM, et al. Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: Independent estimates from a nationally representative mobile phone survey. Vaccine. 2013 Dec 4. pii: S0264-410X(13)01664. PubMed: www.amedeo.com/p2.php?id=24316239&s=vac&pm=badc2a9eebb0fad ABSTRACT available

Share: http://m.amedeo.com/24316239

18. SUAREZ-CASTANEDA E, Pezzoli L, Elas M, Baltrons R, et al. Routine childhood vaccination programme coverage, El Salvador, 2011-In search of timeliness. Vaccine. 2013 Dec 3. pii: S0264-410X(13)01661. PubMed: www.amedeo.com/p2.php?id=24315884&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24315884

PATENTES

United States Patent and Trademark Office (USPTO)

Estrategia de búsqueda “vaccine” en título y abstract

(ABST/vaccine AND ISD/20131210->20131220): 7 patentes recuperadas.

Vacunas Neumococo (Streptococcus pneumoniae)

7 8,603,484 Multivalent pneumococcal polysaccharide-protein conjugate

composition

Adyuvantes

2 8,609,114 Methods of using a vaccine composition containing synthetic

adjuvant

4 8,604,178 Compositions and methods of enhancing immune responses

Vacunas, otras

PAT. Title NO.

1 8,609,392 Method for orthopoxvirus production and purification

2 8,609,114 Methods of using a vaccine composition containing

synthetic adjuvant

3 8,609,108 Gamma-glutamyl transpeptidase attenuated Francisella

4 8,604,178 Compositions and methods of enhancing immune

responses

5 8,603,808 Leishmania vaccine using sand fly salivary immunogen

6 8,603,485 Bystander immune suppression as a predictor for

response to a vaccine

7 8,603,484 Multivalent pneumococcal polysaccharide-protein

conjugate composition

European Patent Office (EPO)

Acumulado entre el 10 y el 20 de diciembre de 2013: 9 patentes recuperadas.

Adyuvantes

4. Vaccine adjuvant composition comprising inulin particles

CPC: IPC: Priority Inventor: Applicant: Publication info: A61K2039/5252 A61K31/715 date: PETROVSKY VAXINE PTY A61K2039/55511 A61K39/145 AU2012274137 (A1) 2011-06- NIKOLAI LTD A61K2039/55561 A61K39/205 2013-12-12 19 (+8) (+2)

Vacunas, otras

1. NUCLEIC ACID MOLECULE ENCODING HEPATITIS B VIRUS CORE PROTEIN AND VACCINE COMPRISING THE SAME

Inventor: Applicant: Priority CPC: Publication info: WEINER IPC: date: UNIV DAVID B [US] A61K2039/53 EP2672992 (A1) PENNSYLVANIA A61K39/29 2011- YAN JIAN [US] A61K39/292 2013-12-18 [US] 02-11 (+1)

2. Therapeutic Cancer Vaccine

Inventor: Applicant: KHAMAR CPC: KHAMAR Priority BAKULESH IPC: Publication info: BAKULESH A61K2039/5152 date: MAFATLAL MAFATLAL [IN] A61K2039/55594 A61K39/00 US2013330375 (A1) [IN] 2011- DESAI NIRAV A61K2039/572 A61K39/04 2013-12-12 DESAI NIRAV 02-28 MANOJKUMAR (+3) MANOJKUMAR [IN] (+4) [IN] (+3)

3. Vaccine for oral administration to farm animals

Inventor: Applicant: Priority IPC: Publication info: RYCHLIK IVAN date: [CZ] VYZK STAV CPC: A61K39/112 CZ20120361 (A3) KARASOVA VETERINARNIHO 2012- C12N1/21 2013-12-11 DANIELA [CZ] LUKARSTVI [CZ] 05-30 (+4)

4. Vaccine adjuvant composition comprising inulin particles

CPC: IPC: Priority Inventor: Publication info: Applicant: A61K2039/5252 A61K31/715 date:

PETROVSKY A61K2039/55511 A61K39/145 AU2012274137 (A1) VAXINE PTY LTD 2011- NIKOLAI A61K2039/55561 A61K39/205 2013-12-12 06-19 (+8) (+2)

5. THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1 IN CHILDREN, APPLICATION OF THE CELL SORTER AND THE METHOD OF MULTIPLYING TREG CELLS TO PRODUCE THERAPEUTIC VACCINE FOR TREATMENT OF DIABETES TYPE 1

Inventor: CPC: Priority TRZONKOWSKI Applicant: IPC: Publication info: A61K2035/122 date: PIOTR [PL] GDANSKI UNIV A61K35/26 A61K35/26 WO2013184011 (A1) MYSLIWIEC 2012- MEDYCZNY [PL] C12N2320/30 C12N5/0783 2013-12-12 MALGORZATA 06-06 (+1) [PL] (+1)

6. VACCINE

Inventor: CPC: IPC: Applicant: Priority HOEIE LARS Publication info: A61K31/00 A61K31/00 date: [NO] BIONOR A61K31/19 A61K31/19 WO2013182662 (A1) LUNDEMOSE IMMUNO AS 2012- A61K39/00 A61K39/00 2013-12-12 ANKER [NO] [NO] 06-06 (+1) (+1) (+5)

7. Vaccine

Inventor: CPC: Priority IPC: Publication info: STAFFLER Applicant: date: GUENTHER A61K2039/55505 A61K39/00 EP2671592 (A2) [AT] AFFIRIS AG [AT] A61K2039/6081 2009- C07K7/14 2013-12-11 LUEHRS PETRA A61K39/0008 07-23 [AT] (+4)

8. NUCLEIC ACID MOLECULES ENCODING NOVEL HERPES ANTIGENS, VACCINE COMPRISING THE SAME, AND METHODS OF USE THEREOF

Inventor: CPC: Applicant: Priority Publication info: WEINER A61K2039/53 IPC: date: UNIV DAVID B [US] A61K39/245 EP2670443 (A2) PENNSYLVANIA A61K48/00 2011- SHEDLOCK C07K14/005 2013-12-11 [US] 01-31 DEVON J [US] (+4)

9. USE OF A FOOD ADDITIVE BASED ON AT LEAST ONE PHYTONUTRIENT FOR STIMULATING VACCINE IMMUNITY AGAINST APICOMPLEXA IN ANIMALS

Inventor: CPC: IPC: Priority Applicant: Publication info: BRAVO DAVID date: A23K1/14 A23K1/14 [CH] PANCOSMA S A EP2670255 (A1) A23K1/1612 A23K1/16 2011- LILLEHOJ [CH] 2013-12-11 A23K1/1826 A23K1/18 02-01 HYUN [US]

TABLAS DE CONTENIDO

Revista Vaccine

New Articles in Press, 10 December-16 December 2013.

1. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae Original Research Article

Available online 14 December 2013 Sari H. Pakkanen, Jussi M. Kantele, Christian Herzog, Anu Kantele

2. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era Original Research Article

Available online 14 December 2013 Gianvincenzo Zuccotti, Chiara Mameli, Laura Daprai, Maria Laura Garlaschi, Dario Dilillo, Giorgio Bedogni, Marino Faccini, Maria Gramegna, Erminio Torresani, For the PneuMi Study Group (PMSG)

3. Accuracy of traditional and novel serology tests for predicting cross- protection in foot-and-mouth disease vaccinated cattle

Available online 14 December 2013 Bárbara Patricia Brito, Andrés Maximiliano Perez, Alejandra Victoria Capozzo

4. Randomized controlled trial of two dosing schedules for human papillomavirus vaccination among college age males Original Research Article

Available online 14 December 2013 Chyongchiou Jeng Lin, Richard K. Zimmerman, Mary Patricia Nowalk, Hsin-Hui Huang, Jonathan M. Raviotta

5. Gamma ray sterilization of delta inulin adjuvant particles (Advax™) makes minor, partly reversible structural changes without affecting adjuvant activity Original Research Article

Available online 14 December 2013 P.D. Cooper, T.G. Barclay, M. Ginic-Markovic, N. Petrovsky

6. BacMam virus-based surface display of the infectious bronchitis virus (IBV) S1 glycoprotein confers strong protection against virulent IBV challenge in chickens Original Research Article

Available online 14 December 2013 Jie Zhang, Xiao-Wei Chen, Tie-Zhu Tong, Yu Ye, Ming Liao, Hui-Ying Fan

7. The relationship between concentration of specific antibody at birth and subsequent response to primary immunization Original Research Article

Available online 14 December 2013 Christine Jones, Louisa Pollock, Sara M. Barnett, Anna Battersby, Beate Kampmann

8. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains Original Research Article

Available online 14 December 2013 Yo Han Jang, Eun-Young Lee, Young Ho Byun, Eun-Ju Jung, Yoon Jae Lee, Yun Ha Lee, Kwang-Hee Lee, Jinhee Lee, Baik Lin Seong

9. Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response Original Research Article

Available online 14 December 2013 Michael Maynard-Smith, Helen Ahern, Joanna McGlashan, Philip Nugent, Roger Ling, Harriet Denton, Ruth Coxon, John Landon, April Roberts, Clifford Shone

10. Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stability Original Research Article

Available online 14 December 2013 Viviane M. Gonçalves, Waldely O. Dias, Campos B. Ivana, Celia Liberman, Maria E. Sbrogio-Almeida, Eliane P. Silva, Celso P. Cardoso, Mark Alderson, George Robertson, Jeff F. Maisonneuve, Andrea Tate, Porter Anderson, Richard Malley, Fernando Fratelli, Luciana C.C. Leite

11. A mucosal adjuvant for the inactivated poliovirus vaccine Original Research Article

Available online 13 December 2013 Benjamin P. Steil, Patricia Jorquera, Janny Westdijk, Wilfried A.M. Bakker, Robert E. Johnston, Mario Barro

12. Antibody but not memory B-cell responses are tuned-down in vertically HIV- 1 infected children and young individuals being vaccinated yearly against influenza Original Research Article

Available online 13 December 2013 Stefano Rinaldi, Paola Zangari, Nicola Cotugno, Emma Concetta Manno, Noemi Brolatti, Maria Rita Castrucci, Isabella Donatelli, Paolo Rossi, Paolo Palma, Alberto Cagigi

13. Evaluation of recombinant fusion protein comprising dog zona pellucida glycoprotein-3 and Izumo and individual fragments as immunogens for contraception Original Research Article

Available online 13 December 2013 Abhinav Shrestha, Neerja Wadhwa, Satish Kumar Gupta

14. Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell

transplant recipients Original Research Article

Available online 12 December 2013 Nathalie Dhédin, Anne Krivine, Nicole Le Corre, Alain Mallet, Bruno Lioure, Jacques- Olivier Bay, Marie-Thérèse Rubio, Philippe Agape, Anne Thiébaut, Jérôme Le Goff, Brigitte Autran, Patricia Ribaud

15. Trend of human rabies prophylaxis in developing countries: Toward optimal rabies immunization

Available online 9 December 2013 Mary J. Warrell

16. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea- Bissau Original Research Article

Available online 8 December 2013 Ane Bærent Fisker, Henrik Ravn, Amabelia Rodrigues, Marie Drivsholm Østergaard, Carlito Bale, Christine Stabell Benn, Peter Aaby

17. Type I interferon-dependent activation of NK cells by rAd28 or rAd35, but not rAd5, leads to loss of vector-insert expression Original Research Article

Available online 8 December 2013 Matthew J. Johnson, Niklas K. Björkström, Constantinos Petrovas, Frank Liang, Jason G.D. Gall, Karin Loré, Richard A. Koup

Volume 31, Supplement 7, Pages H1-H84, 31 December 2013.

Comprehensive Control of HPV Infections and Related Diseases in the Central and Eastern Europe and Central Asia Region Edited by F.X. Bosch, M. Poljak, S.I. Rogovskaya, X. Castellsagué, M. Brotons and S. Syrjänen We acknowledge with gratitude the support received from the following government and corporate organizations:Partial support for this project was received from The Bill and Melinda Gates Foundation (grant reference V20-181-15) for the development of the WHO/ICO Information Centre on HPV and Cancer; Spanish public grants from Instituto de Salud Carlos III (Spanish Government) (grants RCESP C03/09, RTICESP C03/10, RTICRD06/0020/0095, RD12/0036/0056 and CIBERESP) and from the Agència de Gestió d’Ajuts Universitaris i de Recerca – Generalitat de Catalunya (Catalan Government) (grants AGAUR 2005SGR00695 and AGAUR 2009SGR126), and from B-DEBATE International Center for Scientific Debate Barcelona/BIOCAT. The work of the editors was partially supported by grants from the European Comission (7th Framework Programme grant HEALTH-F3-2010-242061, PREHDICT).

1. Editorial Board/Aims and Scope

Pages CO2

2. Prevention of Cervical Cancer in Central and Eastern Europe and Central Asia:

A Challenge for the Future

Pages vii-ix Vesna Kesic

3. The Path to Eliminate Cervical Cancer in the World and the Challenges of Professional Education

Pages xi-xii F. Xavier Bosch, on behalf of the Editors

4. Contributors ICO Monograph Series on HPV and Disease Prevention

Pages xiii-xviii

5. Acknowledgements

Pages xxi

6. Comprehensive Control of Human Papillomavirus Infections and Related Diseases Review Article

Pages H1-H31 F. Xavier Bosch, Thomas R. Broker, David Forman, Anna-Barbara Moscicki, Maura L. Gillison, John Doorbar, Peter L. Stern, Margaret Stanley, Marc Arbyn, Mario Poljak, Jack Cuzick, Philip E. Castle, John T. Schiller, Lauri E. Markowitz, William A. Fisher, Karen Canfell, Lynette A. Denny, Eduardo L. Franco, Marc Steben, Mark A. Kane, Mark Schiffman, Chris J.L.M. Meijer, Rengaswamy Sankaranarayanan, Xavier Castellsagué, Jane J. Kim, Maria Brotons, Laia Alemany, Ginesa Albero, Mireia Diaz, Silvia de Sanjosé, on behalf of the authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012

7. Patterns and Trends in Human Papillomavirus-Related Diseases in Central and Eastern Europe and Central Asia Review Article

Pages H32-H45 Freddie Bray, Joannie Lortet-Tieulent, Ariana Znaor, Maria Brotons, Mario Poljak, Marc Arbyn

8. Human Papillomavirus Prevalence and Type-Distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in Russian Federation, the Western Countries of the former Soviet Union, Caucasus Region and Central Asia Review Article

Pages H46-H58 Svetlana I. Rogovskaya, Irina P. Shabalova, Irina V. Mikheeva, Galina N. Minkina, Nataly M. Podzolkova, Olga Y. Shipulina, Said N. Sultanov, Iren A. Kosenko, Maria Brotons, Nina Buttmann, Myassa Dartell, Marc Arbyn, Stina Syrjänen, Mario Poljak

9. Human Papillomavirus Prevalence and Type-Distribution, Cervical Cancer Screening Practices and Current Status of Vaccination Implementation in Central and Eastern Europe Review Article

Pages H59-H70 Mario Poljak, Katja Seme, Polona J. Maver, Boštjan J. Kocjan, Kate S. Cuschieri, Svetlana I. Rogovskaya, Marc Arbyn, Stina Syrjänen

10. Cost-Effectiveness of Cervical Cancer Prevention in Central and Eastern Europe and Central Asia Review Article

Pages H71-H79 Johannes Berkhof, Johannes A. Bogaards, Erhan Demirel, Mireia Diaz, Monisha Sharma, Jane J. Kim

11. Recommendations for Cervical Cancer Prevention in Central and Eastern Europe and Central Asia

Pages H80-H82 Mario Poljak, Svetlana I. Rogovskaya, Vesna Kesić, Freddie Bray, Johannes Berkhof, Katja Seme, Maria Brotons, Xavier Castellsagué, Stina Syrjänen, Marc Arbyn, F. Xavier Bosch

12. Disclosure of financial support

Pages H83

Volume 32, Issue 2, Pages 205-310, 3 January 2014.

1. Editorial Board/Aims and Scope

Pages CO2

Letters to the Editor

2. Flu vaccination goes mobile

Pages 205-206 Laura von Gierke, Sabine Wicker

3. Practices, beliefs and attitudes associated with support for mandatory influenza vaccination among Spanish medical students

Pages 207-208 Ignacio Hernández-García, Luis-Félix Valero

Short communication

4. A novel site-II directed glycoprotein estimation ELISA to aid rabies vaccine manufacture for veterinary and human use

Pages 209-213 Gontu Abhinay, Scott Dessain, Adabala Srikanth, R.L. Senthilkumar, Pitta Vidyasagar, Alagangula Praveen, R.V. Chandrasekhar Reddy, Erri Swapna Reddy, Lingala Rajendra

Brief report

5. Vaccination of cattle with a recombinant bivalent toxoid against botulism serotypes C and D

Pages 214-216 Carlos E.P. Cunha, Gustavo M.S.G. Moreira, Felipe M. Salvarani, Monique S. Neves, Francisco C.F. Lobato, Odir A. Dellagostin, Fabricio R. Conceição

Review

6. A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination Review Article

Pages 217-222 Tran Hien Nguyen, Minh Huong Vu, Van Cuong Nguyen, Lien Huong Nguyen, Kohei Toda, Tuyet Nga Nguyen, Sang Dao, Kathleen A. Wannemuehler, Karen A. Hennessey

Regular papers

7. Co-administration of tilapia alpha-helical antimicrobial peptides with subunit antigens boost immunogenicity in mice and tilapia (Oreochromis niloticus) Original Research Article

Pages 223-229 Jannel Acosta, Yamila Carpio, Iris Valdés, Janet Velázquez, Yasser Zamora, Reynold Morales, Antonio Morales, Elsa Rodríguez, Mario P. Estrada

8. A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 U.S. variant mPCV2b strain Original Research Article

Pages 230-237 Tanja Opriessnig, Priscilla F. Gerber, Chao-Ting Xiao, Mark Mogler, Patrick G. Halbur

9. Immunologic characterization of a novel inactivated nasal mumps virus vaccine adjuvanted with Protollin Original Research Article

Pages 238-245

Katie R. Young, Sazini Nzula, David S. Burt, Brian J. Ward

10. System factors to explain 2009 pandemic H1N1 state vaccination rates for children and high-risk adults in US emergency response to pandemic Original Research Article

Pages 246-251 Carlo Davila-Payan, Julie Swann, Pascale M. Wortley

11. Evaluating the clinical effectiveness of pneumococcal vaccination in preventing myocardial infarction: The CAPAMIS study, three-year follow-up Original Research Article

Pages 252-257 O. Ochoa-Gondar, A. Vila-Corcoles, T. Rodriguez-Blanco, C. de Diego- Cabanes, I. Hospital-Guardiola, M. Jariod-Pamies, on behalf of EPIVAC Research Group

12. Development of a small animal peripheral challenge model of Japanese encephalitis virus using interferon deficient AG129 mice and the SA14-14-2 vaccine virus strain Original Research Article

Pages 258-264 Amanda E. Calvert, Kandice L. Dixon, Mark J. Delorey, Carol D. Blair, John T. Roehrig

13. Synergistic induction of interferon α through TLR-3 and TLR-9 agonists stimulates immune responses against measles virus in neonatal cotton rats Original Research Article

Pages 265-270 Dhohyung Kim, Stefan Niewiesk

14. Protection against Vibrio vulnificus infection by active and passive immunization with the C-terminal region of the RtxA1/MARTXVv protein Original Research Article

Pages 271-276 Tae Hee Lee, Mi Hyun Kim, Chang-Seop Lee, Ju-Hyung Lee, Joon Haeng Rhee, Kyung Min Chung

15. Different vaccination strategies in Spain and its impact on severe varicella and zoster Original Research Article

Pages 277-283 Ruth Gil-Prieto, Stefan Walter, Alba Gonzalez-Escalada, Laura Garcia- Garcia, Patricia Marín-García, Angel Gil-de-Miguel

16. Timeliness of infant vaccination and factors related with delay in Flanders, Belgium Original Research Article

Pages 284-289

Tinne Lernout, Heidi Theeten, Niel Hens, Tessa Braeckman, Mathieu Roelants, Karel Hoppenbrouwers, Pierre Van Damme

17. Immunogenicity of highly conserved recombinant VacJ outer membrane lipoprotein of Pasteurella multocida Original Research Article

Pages 290-296 Sathish Bhadravati Shivachandra, Abhinendra Kumar, Revanaiah Yogisharadhya, K.N. Viswas

18. DNA-based adaptive immunity protect host from infection-associated periodontal bone resorption via recognition of Porphyromonas gingivalis virulence component Original Research Article

Pages 297-303 Xiaozhe Han, Karen B. LaRosa, Toshihisa Kawai, Martin A. Taubman

Japanese Society for Vaccinology paper

19. Current situation of tuberculosis in Japan and requirement for new vaccine

Pages 304-305 Satoshi Mitarai

Corrigenda

20. Corrigendum to “Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants” [Vaccine 26 (2008) 2234–2241]

Pages 306-308 John C. Victor, Salvacion Gatchalian, Yafu Yao, Benli Zhou, Lei Zhang, Sutee Yoksan, Mansour Yaïch, Kathleen M. Neuzil

21. Corrigendum to “Vaccination with HPV16 L2E6E7 fusion protein in GPI- 0100 adjuvant elicits protective humoral and cell-mediated immunity” [Vaccine 27 (2009) 1040–1049]

Pages 309 Balasubramanyam Karanam, Ratish Gambhira, Shiwen Peng, Subhashini Jagu, Dae-Jin Kim, Gary W. Ketner, Peter L. Stern, Robert J. Adams, Richard B.S. Roden

